Arrhythmias & electrophysiology
Public procurement of cardiac implantable electronic devices across Europe: are we purchasing value or cost-effectiveness?
An erratum to this article was published (Europace, 10 Mar 2026 ↗)
Authors' conclusion
Cardiac implantable electronic device procurement across Europe is heterogeneous and predominantly cost driven, with limited integration of clinical outcomes or value-based principles.
Study context
- Population
- Cardiologists and one industry expert in 22 European countries with mandatory public tendering for cardiac implantable electronic devices (CIEDs)
- Participants
- 23 structured interviews
- Outcome
- CIED procurement models, clinician involvement and reimbursement
Methodological detailsstructured interviews, thematic analysis, 22 European countries
- Structured interviews
- Thematic analysis
- 22 European countries
Main finding
As reported in the abstract
Procedure tariffs for single-chamber pacemakers
€1059 to €14 889
Original publication
Public procurement of cardiac implantable electronic devices across Europe: are we purchasing value or cost-effectiveness? Europace. Published 18 February 2026. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →